Thanks to Femtech Insider for this profile of our new CEO Colby Holtshouse and our mission to address #PCOS for the millions of women whose needs are not met today.
🔬 For women suffering from Polycystic Ovary Syndrome (PCOS), treatment options have remained largely unchanged for decades. May Health is working to change that with its Ovarian Rebalancing technology, a novel approach that targets the root cause of PCOS-related infertility. Leading this mission is the company’s newly appointed President and CEO, Colby Holtshouse, who brings extensive experience in women’s health and medtech innovation. 💬 “After my first women’s health startup, I said I would never do it again – many investors were hesitant, strategics were not active, there are so many headwinds. But the landscape has improved significantly since 2017. There’s a new level of awareness, more proof points for commercial success, and growing interest from investors willing to put money into novel solutions in this space.” Colby Holtshouse, May Health CEO #femtech #womenshealth #womenshealthinnovation #health #healthcare #healthtech #medtech #pcos #fertility #reproductivehealth #company #startup #ceo